Hartwig Medical Foundation welcomes new managing director

Hartwig Medical Foundation is pleased to announce that Robert Jan Lamers has joined the organization as its new managing director, effective September 1. He steps into the role after Hans van Snellenberg. Lamers’ arrival marks a new phase for Hartwig, as the organization evolves from a pioneer in DNA analysis into a leading innovator in data-driven, personalized cancer care.
At the interface of healthcare and data
Lamers has a background in biotechnology and over twenty years of experience leading innovative organizations at the crossroads of healthcare, data, and technology. He has previously headed several scale-ups and built a strong network within the (international) biotech- and healthcare sectors.
‘In Robert Jan Lamers we have found a new managing director who will build on the success of Hartwig Medical Foundation. With his leadership, we aim to accelerate progress even further and expand access for patients and physicians to precision diagnostics and personal treatments. He is a unifying leader with strategic vision who will guide Hartwig into its next phase of impact and growth.’ – Constantijn van Oranje, chair of the Supervisory Board of Hartwig Medical Foundation.

Driving greater impact
Lamers is eager to begin this new chapter with Hartwig Medical Foundation.
You read an article in the category Hartwig Medical Foundation. All news‘What appeals to me about Hartwig is the unique combination of patient focus, innovation, scientific depth, and societal impact. Together with dedicated partners and a strong team, we are committed to advancing cancer care. I look forward to meeting our partners and working together to achieve even greater impact for more patients.’ – Robert Jan Lamers
Also read
Hartwig tools now available as a nextflow nf-core pipeline called oncoanalyser
The University of Melbourne Centre for Cancer Research (UMCCR) Genomics Platform Group, led by Professor Oliver Hofmann, has collaborated with …
Hartwig Medical Foundation welcomes Eliëtte Vaal to its Supervisory Board
Hartwig Medical Foundation (Hartwig) has welcomed Eliëtte Vaal as a new member of its Supervisory Board. Her appointment reflects Hartwig’s …
Warnyta Minnaard represents patient interests and possibilities
Frank van Wijck, science journalist Warnyta Minnaard has been a member of Hartwig Medical Foundation’s Data Access Board (DAB) since February …
By using WGS, we took a step forward in molecular diagnostics in our department from the analysis of less than 100 genes to approximately 20,000 genes per patient. This provides an enormous amount of valuable information, not only for the patient of today, but also for the patient of the future.